MRI-targeted or standard biopsy for prostate-cancer diagnosis Academic Article uri icon

Overview

MeSH Major

  • Biopsy
  • Magnetic Resonance Imaging
  • Prostate
  • Prostatic Neoplasms

abstract

  • The use of risk assessment with MRI before biopsy and MRI-targeted biopsy was superior to standard transrectal ultrasonography-guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously. (Funded by the National Institute for Health Research and the European Association of Urology Research Foundation; PRECISION ClinicalTrials.gov number, NCT02380027 .).

authors

publication date

  • May 10, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1801993

PubMed ID

  • 29552975

Additional Document Info

start page

  • 1767

end page

  • 1777

volume

  • 378

number

  • 19